Ironwood Pharmaceuticals reported $0.14 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q2 Jun/2025 0.14 0.03 -0.01 Aug/07 2025
FY2024Q4 Dec/2024 0.02 0.06 -0.01 Feb/27 2025
FY2024Q3 Sep/2024 0.02 0.07 0.12 Nov/07 2024
FY2024Q2 Jun/2024 -0.01 0.16 0.31 Aug/08 2024
FY2024Q1 Mar/2024 -0.02 0.20 0.25 May/09 2024
FY2023Q4 Dec/2023 -0.01 -0.01 0.27 Feb/15 2024
FY2023Q3 Sep/2023 0.12 0.16 0.28 Nov/09 2023
FY2023Q2 Jun/2023 0.31 0.26 0.21 Aug/08 2023
FY2023Q1 Mar/2023 0.25 0.23 0.21 May/04 2023
FY2022Q4 Dec/2022 0.27 0.26 0.27 Feb/16 2023
FY2022Q3 Sep/2022 0.28 0.26 0.33 Nov/03 2022
FY2022Q2 Jun/2022 0.21 0.30 0.34 Aug/04 2022


Eps Change Date
Acadia Pharmaceuticals USD 0.16 0.05 Jun/2025
Agios Pharmaceuticals USD -1.93 0.38 Jun/2025
Almirall EUR 0.02 0.08 Jun/2025
Alnylam Pharmaceuticals USD 0.32 0.33 Jun/2025
Amarin USD -0.03 0.01 Jun/2025
Ardelyx USD -0.08 0.1 Jun/2025
Astellas Pharma JPY 38.22 3.62 Jun/2025
AstraZeneca USD 2.17 0.32 Jun/2025
Charles River Laboratories USD 3.12 0.78 Jun/2025
Exact Sciences USD -0.01 0.53 Jun/2025
Halozyme Therapeutics USD 1.54 0.43 Jun/2025
Incyte USD 1.57 0.41 Jun/2025
Ironwood Pharmaceuticals USD 0.14 0.12 Jun/2025
MacroGenics USD -0.57 0.32 Jun/2025
Moderna USD -2.13 0.39 Jun/2025
Myriad Genetics USD 0.05 0.08 Jun/2025
Pacira USD 0.74 0.12 Jun/2025
PTC Therapeutics USD -0.83 10.87 Jun/2025
Sarepta Therapeutics USD 2.02 5.44 Jun/2025
Takeda JPY 79.4 145.4 Jun/2025
Ultragenyx Pharmaceutical USD -1.17 0.4 Jun/2025